arrow
M

Mark E. Cooper

monash university
H指数:123
被引数:7.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Potential bone marrow–driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes

通过司美格鲁肽降低2型糖尿病患者骨髓驱动的循环炎性单核细胞

2026-09-290
OAAI
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation

胰高血糖素样肽-1受体信号通过抑制晚期糖基化终产物诱导的炎症反应改变糖尿病肾病的程度

2024-01-0125
OA
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitus

循环表观基因组生物标志物与2型糖尿病高危人群的肾脏疾病易感性相对应

2023-10-011
OAAI